Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Disease, Chronic Obstructive | 84 | 2024 | 3202 | 6.890 |
Why?
|
Pulmonary Emphysema | 19 | 2024 | 685 | 3.400 |
Why?
|
Emphysema | 5 | 2024 | 238 | 1.760 |
Why?
|
Lung | 31 | 2024 | 9973 | 1.470 |
Why?
|
Genome-Wide Association Study | 45 | 2024 | 12653 | 1.460 |
Why?
|
Smoking | 26 | 2023 | 9046 | 1.420 |
Why?
|
Genetic Predisposition to Disease | 43 | 2024 | 17854 | 1.360 |
Why?
|
Idiopathic Pulmonary Fibrosis | 7 | 2024 | 500 | 1.340 |
Why?
|
Forced Expiratory Volume | 20 | 2023 | 1812 | 1.330 |
Why?
|
Spirometry | 13 | 2023 | 928 | 1.240 |
Why?
|
Genetic Loci | 8 | 2019 | 2626 | 1.130 |
Why?
|
Gene Expression | 8 | 2021 | 7582 | 0.840 |
Why?
|
Polymorphism, Single Nucleotide | 29 | 2024 | 15867 | 0.820 |
Why?
|
Quantitative Trait Loci | 10 | 2024 | 2104 | 0.760 |
Why?
|
Gene Regulatory Networks | 7 | 2024 | 1739 | 0.760 |
Why?
|
alpha 1-Antitrypsin | 3 | 2022 | 170 | 0.720 |
Why?
|
Cluster Analysis | 7 | 2022 | 2711 | 0.680 |
Why?
|
Sequence Analysis, RNA | 8 | 2022 | 2018 | 0.680 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2019 | 71 | 0.640 |
Why?
|
Respiratory Function Tests | 11 | 2022 | 1681 | 0.630 |
Why?
|
Molecular Epidemiology | 2 | 2019 | 468 | 0.620 |
Why?
|
RNA, Untranslated | 2 | 2020 | 459 | 0.590 |
Why?
|
Computational Biology | 6 | 2024 | 3510 | 0.590 |
Why?
|
Exons | 4 | 2023 | 2392 | 0.570 |
Why?
|
Gene Expression Profiling | 10 | 2024 | 9410 | 0.560 |
Why?
|
GTPase-Activating Proteins | 2 | 2019 | 471 | 0.540 |
Why?
|
Phenotype | 21 | 2024 | 16585 | 0.510 |
Why?
|
Polyadenylation | 3 | 2024 | 117 | 0.440 |
Why?
|
Chromosomes, Human, Pair 4 | 3 | 2024 | 375 | 0.440 |
Why?
|
Adaptive Immunity | 1 | 2018 | 725 | 0.430 |
Why?
|
Health Care Coalitions | 1 | 2012 | 36 | 0.400 |
Why?
|
Fibroblasts | 2 | 2019 | 4106 | 0.370 |
Why?
|
Disease Progression | 12 | 2023 | 13484 | 0.360 |
Why?
|
Models, Statistical | 4 | 2021 | 5078 | 0.360 |
Why?
|
Classification | 1 | 2011 | 127 | 0.360 |
Why?
|
Protein Isoforms | 4 | 2022 | 1697 | 0.350 |
Why?
|
Respiratory System Agents | 1 | 2010 | 30 | 0.350 |
Why?
|
Community Networks | 1 | 2012 | 201 | 0.350 |
Why?
|
Leukocytes | 1 | 2018 | 2024 | 0.340 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2011 | 385 | 0.340 |
Why?
|
Humans | 119 | 2024 | 760437 | 0.340 |
Why?
|
Health Services for the Aged | 1 | 2012 | 259 | 0.330 |
Why?
|
Nebulizers and Vaporizers | 1 | 2010 | 138 | 0.330 |
Why?
|
Middle Aged | 61 | 2024 | 220382 | 0.320 |
Why?
|
Gene Expression Regulation | 9 | 2024 | 11900 | 0.320 |
Why?
|
Indium Radioisotopes | 1 | 2008 | 113 | 0.320 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2009 | 113 | 0.320 |
Why?
|
Pentetic Acid | 1 | 2008 | 209 | 0.310 |
Why?
|
Aged | 50 | 2024 | 168840 | 0.310 |
Why?
|
Airway Resistance | 1 | 2009 | 406 | 0.310 |
Why?
|
Epoxide Hydrolases | 1 | 2008 | 122 | 0.300 |
Why?
|
Octreotide | 1 | 2008 | 153 | 0.290 |
Why?
|
Proteomics | 8 | 2024 | 3818 | 0.290 |
Why?
|
Male | 67 | 2024 | 360035 | 0.270 |
Why?
|
Female | 68 | 2024 | 391875 | 0.260 |
Why?
|
Immunity, Innate | 1 | 2018 | 3059 | 0.260 |
Why?
|
Tomography, X-Ray Computed | 17 | 2023 | 20551 | 0.240 |
Why?
|
3' Untranslated Regions | 2 | 2024 | 515 | 0.240 |
Why?
|
Aged, 80 and over | 22 | 2022 | 58859 | 0.230 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 1066 | 0.220 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2008 | 1110 | 0.210 |
Why?
|
Severity of Illness Index | 10 | 2022 | 15820 | 0.210 |
Why?
|
Bronchitis, Chronic | 1 | 2023 | 82 | 0.210 |
Why?
|
Databases, Genetic | 1 | 2009 | 1738 | 0.210 |
Why?
|
DNA | 2 | 2020 | 7208 | 0.210 |
Why?
|
Tomography, Spiral Computed | 2 | 2014 | 273 | 0.200 |
Why?
|
Longitudinal Studies | 14 | 2023 | 14565 | 0.200 |
Why?
|
RNA Splice Sites | 1 | 2023 | 211 | 0.200 |
Why?
|
Neuroendocrine Tumors | 1 | 2008 | 642 | 0.200 |
Why?
|
Drug Costs | 1 | 2010 | 1179 | 0.200 |
Why?
|
Smoking Cessation | 2 | 2024 | 2053 | 0.190 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2019 | 613 | 0.190 |
Why?
|
Alternative Splicing | 3 | 2023 | 1091 | 0.190 |
Why?
|
Cachexia | 2 | 2020 | 199 | 0.190 |
Why?
|
Genotype | 6 | 2023 | 12976 | 0.190 |
Why?
|
Marijuana Smoking | 1 | 2024 | 258 | 0.190 |
Why?
|
Desmoplakins | 1 | 2020 | 61 | 0.180 |
Why?
|
Vital Capacity | 5 | 2023 | 970 | 0.180 |
Why?
|
Multifactorial Inheritance | 3 | 2024 | 1378 | 0.180 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4575 | 0.170 |
Why?
|
Asthma | 5 | 2021 | 6195 | 0.170 |
Why?
|
Receptors, Cell Surface | 1 | 2008 | 2819 | 0.160 |
Why?
|
Chromosomes, Human, Pair 15 | 3 | 2015 | 361 | 0.160 |
Why?
|
Pulmonary Eosinophilia | 1 | 2019 | 78 | 0.160 |
Why?
|
Respiration Disorders | 1 | 2022 | 367 | 0.160 |
Why?
|
Radiopharmaceuticals | 1 | 2008 | 2646 | 0.160 |
Why?
|
Activin Receptors, Type I | 1 | 2019 | 134 | 0.160 |
Why?
|
RNA Splicing | 1 | 2023 | 915 | 0.160 |
Why?
|
Case-Control Studies | 9 | 2024 | 22097 | 0.150 |
Why?
|
Medication Adherence | 1 | 2010 | 2166 | 0.150 |
Why?
|
Heme | 1 | 2020 | 313 | 0.150 |
Why?
|
RNA, Messenger | 4 | 2023 | 12785 | 0.150 |
Why?
|
F-Box Proteins | 1 | 2019 | 201 | 0.150 |
Why?
|
Hypertension, Pulmonary | 1 | 2008 | 1580 | 0.150 |
Why?
|
Genetic Pleiotropy | 1 | 2019 | 181 | 0.150 |
Why?
|
Health Expenditures | 1 | 2010 | 2353 | 0.140 |
Why?
|
Predictive Value of Tests | 5 | 2022 | 15257 | 0.140 |
Why?
|
Leukocyte Count | 2 | 2018 | 1596 | 0.140 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 3631 | 0.140 |
Why?
|
Genetic Variation | 5 | 2020 | 6570 | 0.140 |
Why?
|
Linkage Disequilibrium | 2 | 2014 | 2004 | 0.140 |
Why?
|
Cohort Studies | 15 | 2022 | 41366 | 0.140 |
Why?
|
Models, Genetic | 4 | 2024 | 3445 | 0.140 |
Why?
|
Macrophages, Alveolar | 1 | 2019 | 412 | 0.140 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2020 | 790 | 0.140 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2023 | 611 | 0.130 |
Why?
|
Iron Regulatory Protein 2 | 2 | 2015 | 42 | 0.130 |
Why?
|
rac GTP-Binding Proteins | 1 | 2017 | 162 | 0.130 |
Why?
|
Chromosome Mapping | 2 | 2014 | 4630 | 0.130 |
Why?
|
Epigenomics | 2 | 2019 | 940 | 0.130 |
Why?
|
Airway Remodeling | 1 | 2017 | 133 | 0.130 |
Why?
|
Respiratory Mucosa | 1 | 2019 | 439 | 0.130 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2018 | 632 | 0.120 |
Why?
|
Serpin E2 | 2 | 2020 | 48 | 0.120 |
Why?
|
Oxygen | 2 | 2018 | 4222 | 0.120 |
Why?
|
Heterozygote | 1 | 2022 | 2798 | 0.120 |
Why?
|
Axonemal Dyneins | 1 | 2014 | 25 | 0.120 |
Why?
|
Metabolomics | 2 | 2021 | 1653 | 0.120 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2021 | 1031 | 0.120 |
Why?
|
Bronchi | 1 | 2018 | 845 | 0.120 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2189 | 0.120 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 1517 | 0.120 |
Why?
|
Risk Factors | 16 | 2024 | 74055 | 0.110 |
Why?
|
ROC Curve | 1 | 2021 | 3571 | 0.110 |
Why?
|
Airway Obstruction | 1 | 2018 | 661 | 0.110 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 916 | 0.110 |
Why?
|
Chemokines | 1 | 2017 | 960 | 0.110 |
Why?
|
Genomics | 3 | 2018 | 5806 | 0.110 |
Why?
|
Eosinophils | 1 | 2018 | 947 | 0.110 |
Why?
|
Pulmonary Fibrosis | 1 | 2017 | 505 | 0.110 |
Why?
|
Receptors, Nicotinic | 2 | 2015 | 495 | 0.100 |
Why?
|
Metabolic Networks and Pathways | 1 | 2017 | 787 | 0.100 |
Why?
|
Hepatitis C | 1 | 2023 | 1583 | 0.100 |
Why?
|
New South Wales | 1 | 2012 | 69 | 0.100 |
Why?
|
Cytokines | 2 | 2017 | 7377 | 0.100 |
Why?
|
Risk Assessment | 5 | 2022 | 23953 | 0.100 |
Why?
|
Cadherins | 1 | 2017 | 904 | 0.100 |
Why?
|
DNA Methylation | 2 | 2023 | 4383 | 0.100 |
Why?
|
Propensity Score | 1 | 2019 | 1906 | 0.100 |
Why?
|
Proteome | 1 | 2021 | 1861 | 0.100 |
Why?
|
beta Catenin | 1 | 2016 | 1040 | 0.090 |
Why?
|
Pneumothorax | 1 | 2014 | 383 | 0.090 |
Why?
|
Blood Proteins | 1 | 2016 | 1174 | 0.090 |
Why?
|
Genetic Markers | 2 | 2022 | 2612 | 0.090 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2011 | 349 | 0.090 |
Why?
|
PubMed | 1 | 2011 | 128 | 0.090 |
Why?
|
Europe | 1 | 2017 | 3419 | 0.090 |
Why?
|
Epithelial Cells | 2 | 2020 | 3661 | 0.090 |
Why?
|
Genome, Human | 3 | 2015 | 4423 | 0.080 |
Why?
|
Follow-Up Studies | 7 | 2021 | 39078 | 0.080 |
Why?
|
Prospective Studies | 6 | 2023 | 54339 | 0.080 |
Why?
|
Norway | 1 | 2010 | 497 | 0.080 |
Why?
|
Protease Nexins | 1 | 2008 | 39 | 0.080 |
Why?
|
Body Mass Index | 2 | 2017 | 12932 | 0.080 |
Why?
|
Software | 2 | 2020 | 4426 | 0.080 |
Why?
|
Genetic Linkage | 1 | 2014 | 2382 | 0.080 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2017 | 952 | 0.080 |
Why?
|
Pulmonary Surfactant-Associated Protein B | 1 | 2008 | 43 | 0.080 |
Why?
|
Online Systems | 1 | 2009 | 182 | 0.080 |
Why?
|
Genome | 1 | 2016 | 1739 | 0.080 |
Why?
|
Blood Pressure | 1 | 2024 | 8479 | 0.080 |
Why?
|
Biostatistics | 1 | 2010 | 164 | 0.080 |
Why?
|
Health Services | 1 | 2013 | 752 | 0.080 |
Why?
|
Adult | 14 | 2024 | 220781 | 0.070 |
Why?
|
Enhancer Elements, Genetic | 1 | 2014 | 1363 | 0.070 |
Why?
|
Gene Frequency | 2 | 2016 | 3637 | 0.070 |
Why?
|
Glutathione Transferase | 1 | 2009 | 565 | 0.070 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2010 | 348 | 0.070 |
Why?
|
Sepsis | 1 | 2021 | 2583 | 0.070 |
Why?
|
Prognosis | 5 | 2023 | 29551 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2723 | 0.070 |
Why?
|
Hypercapnia | 1 | 2008 | 261 | 0.070 |
Why?
|
Superoxide Dismutase | 1 | 2009 | 592 | 0.070 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7597 | 0.070 |
Why?
|
Linear Models | 1 | 2017 | 5865 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1807 | 0.070 |
Why?
|
False Positive Reactions | 1 | 2008 | 956 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2017 | 20078 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2018 | 8967 | 0.060 |
Why?
|
United States | 5 | 2019 | 72202 | 0.060 |
Why?
|
Logistic Models | 2 | 2019 | 13240 | 0.060 |
Why?
|
Dyspnea | 1 | 2013 | 1344 | 0.060 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3541 | 0.060 |
Why?
|
ras Proteins | 1 | 2011 | 1052 | 0.060 |
Why?
|
Genetics, Population | 1 | 2009 | 939 | 0.060 |
Why?
|
Pattern Recognition, Automated | 1 | 2011 | 996 | 0.060 |
Why?
|
Interviews as Topic | 1 | 2012 | 2683 | 0.060 |
Why?
|
Meta-Analysis as Topic | 2 | 2021 | 1376 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2018 | 11526 | 0.050 |
Why?
|
Nerve Tissue Proteins | 2 | 2015 | 4413 | 0.050 |
Why?
|
Attitude to Health | 1 | 2012 | 2025 | 0.050 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2023 | 189 | 0.050 |
Why?
|
Alleles | 3 | 2020 | 6908 | 0.050 |
Why?
|
Mucin-5B | 1 | 2023 | 148 | 0.050 |
Why?
|
Risk | 1 | 2014 | 9605 | 0.050 |
Why?
|
Bronchodilator Agents | 2 | 2016 | 512 | 0.050 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2014 | 1857 | 0.050 |
Why?
|
Proteinase Inhibitory Proteins, Secretory | 1 | 2021 | 48 | 0.050 |
Why?
|
Genes, Overlapping | 1 | 2021 | 36 | 0.050 |
Why?
|
Penetrance | 1 | 2023 | 388 | 0.050 |
Why?
|
Aging | 1 | 2020 | 8689 | 0.050 |
Why?
|
Codon, Terminator | 1 | 2021 | 125 | 0.050 |
Why?
|
Databases, Factual | 2 | 2021 | 7948 | 0.050 |
Why?
|
Odds Ratio | 3 | 2022 | 9639 | 0.050 |
Why?
|
Qualitative Research | 1 | 2012 | 3008 | 0.050 |
Why?
|
Disease Models, Animal | 3 | 2023 | 18216 | 0.050 |
Why?
|
Genes, Switch | 1 | 2020 | 48 | 0.040 |
Why?
|
Lung Volume Measurements | 1 | 2021 | 375 | 0.040 |
Why?
|
Arylsulfotransferase | 1 | 2019 | 27 | 0.040 |
Why?
|
Stochastic Processes | 1 | 2020 | 356 | 0.040 |
Why?
|
Positive-Pressure Respiration | 1 | 2003 | 638 | 0.040 |
Why?
|
Nicotine | 1 | 2024 | 680 | 0.040 |
Why?
|
Cause of Death | 2 | 2020 | 3686 | 0.040 |
Why?
|
CpG Islands | 1 | 2023 | 1225 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14661 | 0.040 |
Why?
|
Interferons | 1 | 2022 | 704 | 0.040 |
Why?
|
Quality of Life | 3 | 2016 | 13338 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2011 | 4509 | 0.040 |
Why?
|
Comorbidity | 3 | 2018 | 10494 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13312 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15476 | 0.040 |
Why?
|
Time Factors | 2 | 2018 | 39947 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2019 | 739 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2023 | 1078 | 0.040 |
Why?
|
Mutation | 3 | 2023 | 30025 | 0.030 |
Why?
|
Mice | 6 | 2023 | 81402 | 0.030 |
Why?
|
Nedocromil | 1 | 2016 | 45 | 0.030 |
Why?
|
HIV Infections | 1 | 2023 | 17328 | 0.030 |
Why?
|
Socioeconomic Factors | 1 | 2010 | 7817 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5835 | 0.030 |
Why?
|
Pneumonectomy | 1 | 2023 | 1110 | 0.030 |
Why?
|
Counseling | 1 | 2024 | 1545 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2019 | 653 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2018 | 999 | 0.030 |
Why?
|
Acetylation | 1 | 2018 | 1054 | 0.030 |
Why?
|
Hepacivirus | 1 | 2023 | 1337 | 0.030 |
Why?
|
Budesonide | 1 | 2016 | 157 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1790 | 0.030 |
Why?
|
Hepatocytes | 1 | 2021 | 1232 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2531 | 0.030 |
Why?
|
Protein Stability | 1 | 2016 | 577 | 0.030 |
Why?
|
Total Lung Capacity | 1 | 2014 | 149 | 0.030 |
Why?
|
RNA, Viral | 1 | 2023 | 2846 | 0.030 |
Why?
|
Colorectal Neoplasms | 2 | 2011 | 6894 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2018 | 633 | 0.030 |
Why?
|
ABO Blood-Group System | 1 | 2016 | 380 | 0.030 |
Why?
|
Serpins | 1 | 2015 | 247 | 0.030 |
Why?
|
Lysine | 1 | 2018 | 992 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2011 | 9176 | 0.030 |
Why?
|
Epithelium | 1 | 2018 | 1603 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2014 | 80430 | 0.030 |
Why?
|
Adiponectin | 1 | 2019 | 1113 | 0.030 |
Why?
|
Drosophila | 1 | 2020 | 1492 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2016 | 1156 | 0.030 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2014 | 223 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1454 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2721 | 0.030 |
Why?
|
Down-Regulation | 1 | 2020 | 2911 | 0.030 |
Why?
|
Metabolome | 1 | 2019 | 986 | 0.030 |
Why?
|
Incidence | 1 | 2010 | 21322 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2018 | 7996 | 0.030 |
Why?
|
SOXB1 Transcription Factors | 1 | 2014 | 286 | 0.030 |
Why?
|
Demography | 1 | 2017 | 1648 | 0.020 |
Why?
|
Netherlands | 1 | 2016 | 2218 | 0.020 |
Why?
|
Poland | 1 | 2012 | 197 | 0.020 |
Why?
|
Inflammation | 2 | 2023 | 10746 | 0.020 |
Why?
|
Animals | 6 | 2023 | 168253 | 0.020 |
Why?
|
Age Factors | 2 | 2021 | 18379 | 0.020 |
Why?
|
Oximetry | 1 | 2014 | 460 | 0.020 |
Why?
|
Sex Factors | 2 | 2016 | 10538 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2020 | 1897 | 0.020 |
Why?
|
Teratoma | 1 | 2014 | 402 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1805 | 0.020 |
Why?
|
Mesoderm | 1 | 2014 | 673 | 0.020 |
Why?
|
DNA Damage | 1 | 2020 | 2441 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2018 | 18955 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2413 | 0.020 |
Why?
|
Area Under Curve | 1 | 2014 | 1633 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2016 | 1494 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 22121 | 0.020 |
Why?
|
Fibronectins | 1 | 2014 | 723 | 0.020 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2003 | 1870 | 0.020 |
Why?
|
Rest | 1 | 2014 | 915 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1824 | 0.020 |
Why?
|
Child, Preschool | 3 | 2016 | 42209 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 2014 | 835 | 0.020 |
Why?
|
Young Adult | 3 | 2024 | 59068 | 0.020 |
Why?
|
Probability | 1 | 2014 | 2476 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2003 | 3975 | 0.020 |
Why?
|
Survival Analysis | 1 | 2022 | 10075 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2016 | 1834 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2017 | 2326 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2016 | 14397 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3183 | 0.020 |
Why?
|
Histones | 1 | 2018 | 2577 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2011 | 13616 | 0.020 |
Why?
|
Exercise | 1 | 2024 | 5874 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15598 | 0.020 |
Why?
|
Algorithms | 2 | 2019 | 14002 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5764 | 0.020 |
Why?
|
Liver | 1 | 2021 | 7531 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 10180 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6471 | 0.020 |
Why?
|
Collagen | 1 | 2014 | 2637 | 0.020 |
Why?
|
Forecasting | 1 | 2014 | 2925 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2803 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3777 | 0.020 |
Why?
|
Signal Transduction | 2 | 2019 | 23397 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2015 | 3701 | 0.010 |
Why?
|
Treatment Failure | 1 | 2011 | 2642 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2014 | 2413 | 0.010 |
Why?
|
Chronic Disease | 1 | 2019 | 9309 | 0.010 |
Why?
|
Research Design | 1 | 2020 | 6168 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10188 | 0.010 |
Why?
|
Hypertension | 1 | 2024 | 8527 | 0.010 |
Why?
|
Child | 3 | 2016 | 80086 | 0.010 |
Why?
|
Testicular Neoplasms | 1 | 2010 | 799 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12429 | 0.010 |
Why?
|
Computer Simulation | 1 | 2017 | 6230 | 0.010 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 1741 | 0.010 |
Why?
|
Adolescent | 2 | 2024 | 88196 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16945 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2015 | 4936 | 0.010 |
Why?
|
Transcription Factors | 1 | 2022 | 12121 | 0.010 |
Why?
|
Cell Movement | 1 | 2014 | 5198 | 0.010 |
Why?
|
Neoplasms | 1 | 2010 | 22083 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2011 | 6813 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 2019 | 20985 | 0.010 |
Why?
|
MicroRNAs | 1 | 2014 | 3796 | 0.010 |
Why?
|
Thyroid Neoplasms | 1 | 2010 | 2331 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2023 | 36362 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2003 | 1880 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2014 | 26063 | 0.010 |
Why?
|
Attention | 1 | 2003 | 2391 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2003 | 7029 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11095 | 0.000 |
Why?
|